OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the…
Montana’s experimental treatment law hands a VC the keys
Investors on the libertarian fringe of the biotech industry are making their dream of…
Two scientists made huge bets on ‘impossible’ cancer treatments. They’re finally paying off.
Short sellers love to profit from biotech's big fails.The category remains their favorite to…
The Enhanced Games — tech’s steroid extravaganza — didn’t pay off, as company posts $60 million loss
The event ended up being more than a little anticlimactic. Hailed by its creators…
Dimension Capital’s $800M third fund shows the intersection of science and compute is booming
While many newer VC firms are still struggling to raise fresh capital, Dimension Capital,…
What happens in Vega$: steroids, swimmers, and a billion-dollar hustle
I am sitting in the sweltering Nevada heat watching a man struggle to lift…
I went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptides
I am sitting in the sweltering Nevada heat watching a man struggle to lift…
This young startup is taking on a fragrance industry that hasn’t changed in almost half a century
Fragrance tech company Patina says it has raised $2 million in funding investors, including…
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led…
